| Literature DB >> 30161200 |
Thomas Baldwin1, Emir Islamovic2, Kathy Klos1, Paul Schwartz3, James Gillespie3, Samuel Hunter4, Phil Bregitzer1.
Abstract
Deoxynivalenol (DON) contamination of cereal grains caused by Fusarium head blight may be addressed by future RNA interference (RNAi)-based gene silencing approaches. However, utilizing these approaches will require a greater understanding of the principles that govern RNAi effectiveness in the pathogen Fusarium graminearum. RNAi in higher eukaryotes, including fungi, involves processing double stranded RNA (dsRNA) into small interfering RNA (siRNA) that silence gene expression based on base pair complementarity. This study examined virulence, DON production, and the small RNA (sRNA) populations in response to RNAi-based silencing of TRI6, a transcription factor that positively regulates DON synthesis via control of TRI5 expression. Silencing was accomplished via the expression of transgenes encoding inverted repeats targeting various regions of TRI6 (RNAi vectors). Transgene expression was associated with novel, TRI6-specific siRNAs. For RNAi vectors targeting the majority of TRI6 sequence (~600 bp), a discontinuous, repeatable pattern was observed in which most siRNAs mapped to specific regions of TRI6. Targeting shorter regions (250-350 bp) did not alter the siRNA populations corresponding to that region of TRI6. No phased processing was observed. The 5' base of ~83% of siRNAs was uracil, consistent with DICER processing and ARGONAUTE binding preferences for siRNA. Mutant lines showed TRI6 siRNA-associated reductions of TRI5 expression on toxin inducing media and DON in infected wheat and barley spikes. Shorter RNAi vectors resulted in variable levels of silencing that were less than for the ~600 bp RNAi vector, with a 343 bp RNAi vector targeting the 5' end of TRI6 having the best silencing efficiency. This work identifies efficient shorter region for silencing of TRI6 and describes the patterns of siRNA corresponding to those regions.Entities:
Mesh:
Substances:
Year: 2018 PMID: 30161200 PMCID: PMC6116998 DOI: 10.1371/journal.pone.0202798
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
RNAi mutant strains used in this study.
| RNAi mutant strain | NCBI SRA Accession | RNAi fragment length | Start | End | Type of Insertion |
|---|---|---|---|---|---|
| pTRM-TRI6-1 | SRX3857032 | 607 bp | -33 | -640 | Random |
| pTRM-TRI6-4 | SRX3857031 | 607 bp | -33 | -640 | Random |
| pTRM-TRI6-5 | SRX3857030 | 607 bp | -33 | -640 | Random |
| HR1-IIP-TRI6IR-1 | SRX3857029 | 607 bp | -33 | -640 | site-directed |
| HR1-IIP-TRI6IR-2 | SRX3857036 | 607 bp | -33 | -640 | site-directed |
| HR2-IIP-TRI6IR-1 | SRX3857035 | 607 bp | -33 | -640 | site-directed |
| HR2-IIP-TRI6IR-2 | SRX3857034 | 607 bp | -33 | -640 | site-directed |
| HR2-IIP-ShortTRI6IR-1 | SRX3857033 | 253 bp | 0 | -253 | site-directed |
| HR2-IIP-ShortTRI6IR-2 | SRX3857038 | 256 bp | -186 | -443 | site-directed |
| HR2-IIP-ShortTRI6IR-3 | SRX3857037 | 266 bp | -406 | -672 | site-directed |
| HR2-IIP-ShortTRI6IR-4 | SRX3857040 | 342 bp | 0 | -342 | site-directed |
| HR2-IIP-ShortTRI6IR-5 | SRX3857039 | 323 bp | -349 | -672 | site-directed |
a NCBI Bioprojects Sequence Read Archive project number PRJNA446058
bStart and end position based on 5’ end of the TRI6 CDS.
Fig 1Expression of TRI5 via qRT-PCR in PH1, and in pUCH2-8 and TRI6-RNAi mutant strains (full-length and short length) grown on toxin induction media.
The Log2 expression is normalized to PH1. Line bars denote SE of three experiments.
Fig 2Virulence of RNAi mutant strains and PH1 point-inoculated on wheat cultivar Klasic.
(A) Disease severity and DON content of infected kernals. (B) pTRM-TRI6 vs. PH1; pUCH2-8 vs. PH1; pHR2-IIP-TRI6IR and pHR2-IIP-shortTRI6IRs vs PH1 visual infections on wheat. Line bars denote standard errors of three experiments. (M = Mock inoculated).
Small RNA sequencing details.
| Strain | Tech. reps. | Total Reads | Total siRNAs Mapped to | % reads mapped to |
|---|---|---|---|---|
| 1 | 3,067,468 | 271 | 0.01% | |
| #1 | 2 | 6,212,330 | 135,296 | 2.18% |
| #4 | 2 | 4,620,584 | 84,580 | 1.83% |
| #5 | 2 | 6,879,375 | 32,569 | 0.47% |
| #1 | 1 | 2,990,497 | 11,012 | 0.37% |
| #2 | 1 | 3,779,238 | 1,473 | 0.04% |
| #3 | 1 | 3,290,804 | 4,661 | 0.14% |
| #4 | 1 | 4,103,946 | 17,186 | 0.42% |
| #1 | 1 | 4,116,341 | 19,822 | 0.48% |
| #2 | 1 | 2,903,794 | 98,771 | 3.29% |
| #3 | 1 | 4,168,770 | 24,172 | 0.58% |
| #4 | 1 | 3,868,812 | 86,924 | 2.20% |
| #1 | 2 | 9,675,922 | 8,622 | 0.09% |
| #1 | 2 | 5,193,283 | 8,677 | 0.17% |
| #1 | 2 | 3,507,432 | 2,150 | 0.10% |
| #1 | 2 | 12,058,536 | 6,344 | 0.05% |
| #1 | 2 | 11,883,688 | 13,592 | 0.11% |
*Size range from 15–30 nt.
Fig 3The percentage of various sRNAs by length (nt) for (A) total sRNAs and for (B) sRNAs that mapped to TRI6. (C) AUGC proportion of the first base in small RNA in TRI6 RNAi mutants reads that map to TRI6.
Fig 4The average small RNA profiles (map position and relative abundance) of sRNA that mapped to TRI6 (x axis is TRI6 from 5’– 3’) from mutants containing either pTRM-TRI6, HR spots1 and 2 and the Short TRI6 IRs (1–5).
The 20 most-abundant siRNA species that mapped to TRI6 (from all full-length TRI6 RNAi mutant strains analyzed).
| # | Small interfering RNA | Length | Count | % of mapped reads | sense/anti-sense | 5' | 3' | Peak | %GC |
|---|---|---|---|---|---|---|---|---|---|
| 1 | 22 | 34744 | 11.07 | sense | 473 | 494 | 5 | 59.1 | |
| 2 | 19 | 16723 | 5.33 | anti-sense | 435 | 453 | 4 | 52.6 | |
| 3 | 22 | 15816 | 5.04 | anti-sense | 365 | 386 | 3 | 54.5 | |
| 4 | 22 | 14290 | 4.55 | anti-sense | 428 | 449 | 4 | 54.5 | |
| 5 | 20 | 12440 | 3.96 | anti-sense | 434 | 453 | 4 | 50.0 | |
| 6 | 20 | 6108 | 1.95 | anti-sense | 357 | 376 | 3 | 50.0 | |
| 7 | 21 | 5061 | 1.61 | anti-sense | 433 | 453 | 4 | 47.6 | |
| 8 | 21 | 4881 | 1.56 | sense | 473 | 493 | 5 | 57.1 | |
| 9 | 23 | 4610 | 1.47 | sense | 473 | 495 | 5 | 56.5 | |
| 10 | 21 | 4379 | 1.40 | sense | 495 | 515 | 5 | 66.7 | |
| 11 | 23 | 3652 | 1.16 | sense | 20 | 42 | 1 | 52.2 | |
| 12 | 26 | 3032 | 0.97 | sense | 358 | 383 | 3 | 57.7 | |
| 13 | 24 | 2421 | 0.77 | anti-sense | 435 | 458 | 4 | 54.2 | |
| 14 | 21 | 2412 | 0.77 | sense | 368 | 388 | 3 | 52.4 | |
| 15 | 21 | 2293 | 0.73 | sense | 357 | 377 | 3 | 57.1 | |
| 16 | 25 | 2197 | 0.70 | anti-sense | 425 | 449 | 4 | 52.0 | |
| 17 | 22 | 2162 | 0.69 | anti-sense | 551 | 572 | 6 | 50.0 | |
| 18 | 21 | 1929 | 0.61 | anti-sense | 370 | 390 | 3 | 47.6 | |
| 19 | 20 | 1788 | 0.57 | anti-sense | 536 | 555 | 6 | 65.0 | |
| 20 | 19 | 1778 | 0.57 | sense | 368 | 386 | 3 | 52.6 |
Peaks associated with abundant siRNA production (from all full-length TRI6 RNAi mutant strains analyzed).
| Peak | Length | Count | % of mapped reads | sense/anti-sense | 5' | 3' | %GC |
|---|---|---|---|---|---|---|---|
| 1 | 50 | 8120 | 2.11 | sense | 1 | 50 | 62.0 |
| 2 | 50 | 8916 | 2.31 | 51 | 100 | 52.0 | |
| 3 | 50 | 95372 | 24.75 | sense/ | 361 | 410 | 56.0 |
| 4 | 50 | 92526 | 24.01 | 428 | 477 | 52.0 | |
| 5 | 50 | 88688 | 23.02 | sense | 478 | 527 | 60.0 |
| 6 | 50 | 20219 | 5.25 | 542 | 591 | 52.0 | |
| Low GC% | 50 | 77 | 0.02 | - | 107 | 156 | 34.0 |
| 607 | - | - | - | 1 | 607 | 50.4 |